News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,643 Results
Type
Article (39052)
Company Profile (279)
Press Release (646312)
Section
Business (203866)
Career Advice (1991)
Deals (35363)
Drug Delivery (85)
Drug Development (80800)
Employer Resources (168)
FDA (16088)
Job Trends (14805)
News (344547)
Policy (32437)
Tag
Academia (2530)
Alliances (49087)
Alzheimer's disease (1229)
Approvals (16020)
Artificial intelligence (130)
Bankruptcy (352)
Best Places to Work (11538)
Biotechnology (200)
Breast cancer (120)
Cancer (1087)
Cardiovascular disease (97)
Career advice (1660)
Cell therapy (234)
Clinical research (64252)
Collaboration (388)
Compensation (200)
COVID-19 (2530)
C-suite (94)
Data (1126)
Diabetes (152)
Diagnostics (6139)
Earnings (84821)
Employer resources (146)
Events (109490)
Executive appointments (310)
FDA (16627)
Funding (353)
Gene therapy (178)
GLP-1 (577)
Government (4325)
Healthcare (18669)
Infectious disease (2615)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16303)
Job creations (3624)
Job search strategy (1417)
Layoffs (412)
Legal (7853)
Lung cancer (170)
Manufacturing (176)
Medical device (13174)
Medtech (13179)
Mergers & acquisitions (19141)
Metabolic disorders (402)
Neuroscience (1504)
NextGen Class of 2024 (6499)
Non-profit (4464)
Northern California (1481)
Obesity (232)
Opinion (179)
Patents (102)
People (56274)
Phase I (19955)
Phase II (28303)
Phase III (21099)
Pipeline (458)
Postmarket research (2554)
Preclinical (8494)
Radiopharmaceuticals (236)
Rare diseases (219)
Real estate (5890)
Regulatory (21525)
Research institute (2309)
Resumes & cover letters (349)
Southern California (1302)
Startups (3562)
United States (13499)
Vaccines (549)
Weight loss (168)
Date
Today (78)
Last 7 days (667)
Last 30 days (3727)
Last 365 days (35685)
2024 (32750)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (192)
Asia (37123)
Australia (6059)
California (3331)
Canada (1295)
China (252)
Colorado (147)
Connecticut (153)
Europe (79506)
Florida (461)
Georgia (116)
Illinois (341)
Indiana (196)
Kansas (96)
Maryland (575)
Massachusetts (2610)
Michigan (158)
Minnesota (273)
New Jersey (957)
New York (964)
North Carolina (702)
Northern California (1481)
Ohio (139)
Pennsylvania (847)
South America (1091)
Southern California (1302)
Texas (465)
Utah (90)
Washington State (362)
685,643 Results for "oncotelic inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Oncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.
Oncotelic Therapeutics, Inc., announced that it has entered into a binding term-sheet with Mosaic ImmunoEngineering, Inc. under which Mosaic will acquire rights to Oncotelic’s clinical-stage necroptosis cancer therapies.
April 29, 2024
·
7 min read
Press Releases
ONCOTELIC CLINICAL PRESENTATIONS AT SITC 2024
November 7, 2024
·
4 min read
Business
Mosaic ImmunoEngineering Agrees to Acquire Clinical Necroptosis Cancer Therapy Assets from Oncotelic Therapeutics, Inc.
Mosaic ImmunoEngineering, Inc today announced the signing of a binding term-sheet with Oncotelic Therapeutics, Inc.
April 29, 2024
·
6 min read
Biotech Beach
ONCOTELIC TO PARTICIPATE AT THE ASCO 2024 MEETING
Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its Chief Clinical Officer- Dr. Anthony Maida will be participating at the ASCO 2024 meeting.
May 20, 2024
·
4 min read
Biotech Beach
ONCOTELIC TO PARTICIPATE AT THE BIO INTERNATIONAL 2024 MEETING
Oncotelic Therapeutics, Inc announced today its CEO- Dr. Vuong Trieu will be participating at the BIO International 2024 meeting on June3-6, San Diego.
May 30, 2024
·
4 min read
Biotech Beach
ONCOTELIC PRESENTING AT BIOPHARMA NEXUS CONFERENCE SAN DIEGO 2024
Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its presentation at Biopharma Nexus Conference.
May 8, 2024
·
4 min read
Press Releases
ONCOTELIC PUBLISHED ITS FOURTH PUBLICATION ON TGFB2 THERAPEUTICS
October 28, 2024
·
5 min read
Press Releases
ONCOTELIC PRESENTATION AT PRECISION IN DRUG DISCOVERY & PRECLINICAL SUMMIT SAN DIEGO 2024
October 24, 2024
·
4 min read
Biotech Beach
Oncotelic Therapeutics Announces Opening of GMP Manufacturing Plant
Oncotelic Therapeutics, Inc, unveils a state-of-the-art GMP Manufacturing Plant, a significant stride in biopharmaceutical innovation, through its joint venture Sapu Biosciences LLC.
December 18, 2023
·
4 min read
Biotech Beach
Oncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023
Oncotelic Therapeutics, Inc (OTCQB:OTLC) (“Oncotelic”, the “Company” or “We” or “Our”), announced today it was featured in Life Sciences Review, Cancer Immunology Edition and has been awarded a Top Cancer Immunotherapy Solutions Provider 2023 with other aluminous organizations.
August 25, 2023
·
6 min read
1 of 68,565
Next
